Message #14 From:
NewsBot Date: July 26, 2006 05:00:00 AM
AVAN News AVANT to Report Second Quarter Fiscal 2006 Financial Results on August 2, 2006
NEEDHAM, Mass.--(BUSINESS WIRE)--July 26, 2006--
- Conference Call to Follow -
AVANT Immunotherapeutics, Inc. (Nasdaq: AVAN) will release its second quarter fiscal 2006 financial results before U.S. financial markets open on August 2, 2006.
AVANT Immunotherapeutics, Inc. CEO, Una S. Ryan, and CFO, Avery (Chip) W. Catlin, will host a conference call and live audio webcast at 11:00 am ET that same day. To access the live call, dial 866-770-7125 (within the United States) or 617-213-8066 (outside the United States). The passcode for participants is 79009907. A replay will be available approximately two hours after the live call. To access the replay, dial 888-286-8010 (within the United States) or 617-801-6888 (outside the United States). The passcode I.D. # is 52485000. The replay will also be broadcast via the company's website www.avantimmune.com approximately two hours after the live call.
About AVANT Immunotherapeutics, Inc.
AVANT Immunotherapeutics, Inc. discovers and develops innovative vaccines and therapeutics that harness the human immune system to prevent and treat disease. AVANT has three products on the market and six of AVANT's products are in clinical development, including a treatment to reduce complement- mediated tissue damage associated with cardiac bypass surgery and a novel vaccine for cholesterol management. AVANT is also developing a pipeline of products for biodefense, travelers' vaccines, global health, and pandemic flu needs based on AVANT'S rapid-protecting, single-dose, oral and temperature stable vaccine technology.
